Pfizer devotes $150 million to neuroscience in venture capital funding increase
The company, which cut 300 neuroscience R&D jobs in January, is making the funding a centerpiece of its $600 million VC boost.
NeuroVentures
The company, which cut 300 neuroscience R&D jobs in January, is making the funding a centerpiece of its $600 million VC boost.